|
US8263402B1
(en)
*
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US7410798B2
(en)
|
2001-01-10 |
2008-08-12 |
Geron Corporation |
Culture system for rapid expansion of human embryonic stem cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US20050042749A1
(en)
|
2001-05-16 |
2005-02-24 |
Carpenter Melissa K. |
Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
|
|
AU2001263199B2
(en)
|
2000-05-17 |
2004-09-16 |
Asterias Biotherapeutics, Inc. |
Neural progenitor cell populations
|
|
US7250294B2
(en)
|
2000-05-17 |
2007-07-31 |
Geron Corporation |
Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
|
|
US6897061B1
(en)
*
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
|
CA2476376C
(en)
|
2002-02-15 |
2014-10-21 |
Cornell Research Foundation, Inc. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US7207743B2
(en)
*
|
2002-05-28 |
2007-04-24 |
Polivka Parking Solutions Llc |
Method and apparatus for constructing an automotive vehicle parking lot
|
|
US7285415B2
(en)
|
2002-07-11 |
2007-10-23 |
The Regents Of The University Of California |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
AR046076A1
(es)
*
|
2003-07-18 |
2005-11-23 |
Otsuka Pharma Co Ltd |
Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida
|
|
EP1682075A4
(en)
*
|
2003-11-07 |
2009-12-09 |
Univ Florida |
BREEDING AND DIFFERENTIATION OF NEURAL CREATOR CELLS
|
|
US8147806B2
(en)
|
2004-01-16 |
2012-04-03 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
CA2569978C
(en)
*
|
2004-06-09 |
2017-06-06 |
The University Court Of The University Of Edinburgh |
Neural stem cells
|
|
MX2007008668A
(es)
*
|
2005-01-19 |
2008-02-11 |
Fidia Advanced Biopolymers Srl |
Derivado de acido hialuronico y celulas germinales neurales para la regeneracion de una lesion de medula espinal o de una transeccion de nervio periferico.
|
|
US7803364B2
(en)
|
2005-11-17 |
2010-09-28 |
The Cleveland Clinic Foundation |
Multipotent neural stem cells
|
|
JP2009533684A
(ja)
*
|
2006-04-14 |
2009-09-17 |
カーネギー・メロン・ユニバーシティ |
核磁気共鳴技術のための細胞標識及び定量
|
|
US20070258886A1
(en)
*
|
2006-04-14 |
2007-11-08 |
Celsense Inc. |
Methods for assessing cell labeling
|
|
EP2054506A1
(en)
|
2006-08-15 |
2009-05-06 |
Agency for Science, Technology and Research |
Mesenchymal stem cell conditioned medium
|
|
US7927416B2
(en)
|
2006-10-31 |
2011-04-19 |
Sensient Colors Inc. |
Modified pigments and methods for making and using the same
|
|
WO2008131004A1
(en)
*
|
2007-04-17 |
2008-10-30 |
University Of Rochester |
Telencephalic glial-restricted cell populations and related compositions and methods
|
|
AU2008275578B2
(en)
*
|
2007-07-10 |
2014-04-10 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
WO2009026552A2
(en)
|
2007-08-23 |
2009-02-26 |
Sensient Colors Inc. |
Self-dispersed pigments and methods for making and using the same
|
|
EP2240536B1
(en)
|
2008-01-30 |
2019-09-04 |
Asterias Biotherapeutics, Inc. |
Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
|
|
JP2011514169A
(ja)
|
2008-03-17 |
2011-05-06 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
幹細胞培養のためのマイクロキャリア
|
|
ES2611103T3
(es)
*
|
2008-05-02 |
2017-05-04 |
Celsense Inc. |
Composiciones y métodos para producir emulsiones para técnicas de resonancia magnética nuclear y otras aplicaciones
|
|
CA2723382A1
(en)
|
2008-05-08 |
2009-11-12 |
University Of Rochester |
Treating myelin diseases with optimized cell preparations
|
|
US9688956B2
(en)
|
2008-06-05 |
2017-06-27 |
National Cheng Kung University |
Method for preserving proliferation and differentiation potential of mesenchymal stem cells
|
|
US8669048B2
(en)
|
2008-06-24 |
2014-03-11 |
Parkinson's Institute |
Pluripotent cell lines and methods of use thereof
|
|
WO2010068946A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Nova Southeastern University |
Methods of isolating and using stem cells
|
|
US20100158878A1
(en)
|
2008-12-23 |
2010-06-24 |
Alexandra Capela |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
|
US9221986B2
(en)
|
2009-04-07 |
2015-12-29 |
Sensient Colors Llc |
Self-dispersing particles and methods for making and using the same
|
|
SG10201404281YA
(en)
|
2009-07-21 |
2014-09-26 |
Abt Holding Co |
Use of stem cells to reduce leukocyte extravasation
|
|
AU2010276201B2
(en)
|
2009-07-21 |
2013-10-17 |
Healios K.K. |
Use of stem cells to reduce leukocyte extravasation
|
|
JP6002581B2
(ja)
*
|
2010-02-05 |
2016-10-05 |
オークランド ユニサービシズ リミテッドＡｕｃｋｌａｎｄ Ｕｎｉｓｅｒｖｉｃｅｓ Ｌｉｍｉｔｅｄ |
細胞プログラミング
|
|
SG10201501402UA
(en)
|
2010-02-25 |
2015-04-29 |
Abt Holding Co |
Modulation of macrophage activation
|
|
WO2012048298A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
|
US8433419B2
(en)
|
2010-10-13 |
2013-04-30 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlling neurostimulation according to physical state
|
|
KR102073530B1
(ko)
|
2011-06-06 |
2020-02-04 |
리제네시스 비브이비에이 |
중공 섬유 생물 반응기에서의 줄기 세포의 확장
|
|
EP2954046B1
(en)
|
2013-02-06 |
2025-10-15 |
University Of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
|
CA2907327C
(en)
|
2013-03-15 |
2020-04-07 |
Wake Forest University Health Sciences |
Neural progenitor cell differentiation
|
|
AU2014250761B2
(en)
|
2013-04-12 |
2019-02-28 |
Robert J. Deans |
Improving organs for transplantation
|
|
AU2014266935B2
(en)
|
2013-04-30 |
2020-06-11 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
|
WO2015073918A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
US11406721B2
(en)
|
2016-02-22 |
2022-08-09 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
|
US11920155B2
(en)
|
2016-03-30 |
2024-03-05 |
Asterias Biotherapeutics, Inc. |
Oligodendrocyte progenitor cell compositions
|
|
MY192056A
(en)
*
|
2017-01-31 |
2022-07-25 |
Univ Osaka |
Method for controlling differentiation of pluripotent stem cells
|
|
CN110913689A
(zh)
|
2017-05-10 |
2020-03-24 |
罗切斯特大学 |
治疗神经精神病症的方法
|
|
US12365872B2
(en)
|
2018-09-19 |
2025-07-22 |
Lineage Cell Therapeutics, Inc. |
Methods for differentiating pluripotent stem cells in dynamic suspension culture
|
|
US11603518B2
(en)
|
2019-01-23 |
2023-03-14 |
Asterias Biotherapeutics, Inc. |
Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
|
|
EP4017508A1
(en)
|
2019-08-23 |
2022-06-29 |
Sana Biotechnology, Inc. |
Cd24 expressing cells and uses thereof
|
|
MX2022011831A
(es)
|
2020-03-25 |
2023-01-04 |
Sana Biotechnology Inc |
Células neurales hipoinmunogénicas para el tratamiento de trastornos y afecciones neurológicas.
|
|
MX2023001831A
(es)
|
2020-08-13 |
2023-06-29 |
Sana Biotechnology Inc |
Métodos de tratamiento de pacientes sensibilizados con células hipoinmunogénicas y métodos y composiciones asociados.
|
|
KR20240013135A
(ko)
|
2021-05-27 |
2024-01-30 |
사나 바이오테크놀로지, 인크. |
조작된 hla-e 또는 hla-g를 포함하는 저면역원성 세포
|
|
AU2022309875A1
(en)
|
2021-07-14 |
2024-01-25 |
Sana Biotechnology, Inc. |
Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
|
|
EP4384598A1
(en)
|
2021-08-11 |
2024-06-19 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
|
IL310702A
(en)
|
2021-08-11 |
2024-04-01 |
Sana Biotechnology Inc |
Inducible systems for altering gene expression in hypoimmunogenic cells
|
|
EP4384544A1
(en)
|
2021-08-11 |
2024-06-19 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
WO2023019225A2
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
|
WO2025054202A1
(en)
|
2023-09-05 |
2025-03-13 |
Sana Biotechnology, Inc. |
Method of screening a sample comprising a transgene with a unique barcode
|
|
WO2025151838A1
(en)
|
2024-01-12 |
2025-07-17 |
Sana Biotechnology, Inc. |
Safety switches to control in vitro and in vivo proliferation of cell therapy products
|